Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences
June 10 2019 - 4:00PM
Business Wire
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and
development-focused biotechnology company dedicated to creating
small molecule drugs for viral infections and liver diseases, today
announced that Jay R. Luly, Ph.D., President and Chief Executive
Officer, will participate in the following investor
conferences:
June 18, 2019 at 3:00 p.m. ET – Raymond James Life Sciences and
MedTech Conference, New York CityJune 19, 2019 at 9:30 a.m. ET –
JMP Securities Life Sciences Conference, New York City
A live webcast of the presentations will be accessible by
visiting the “Events and Presentations” section on the “Investors”
page of Enanta’s website at www.enanta.com. A replay of the
webcasts will be available following the presentation and will be
archived for approximately 30 days.
About Enanta
Enanta is using its robust, chemistry-driven approach and drug
discovery capabilities to become a leader in the discovery and
development of small molecule drugs for the treatment of viral
infections and liver diseases. Enanta’s research and development
efforts are currently focused on the following disease targets:
respiratory syncytial virus (RSV), non-alcoholic steatohepatitis
(NASH)/ primary biliary cholangitis (PBC), and hepatitis B virus
(HBV).
Enanta’s research and development activities are funded by
royalties from HCV products developed under its collaboration with
AbbVie. Glecaprevir, a protease inhibitor discovered by Enanta, is
now sold by AbbVie in numerous countries as part of its newest
treatment for chronic hepatitis C virus (HCV) infection. This
leading HCV regimen is sold under the tradenames MAVYRET™ (U.S.)
and MAVIRET™ (ex-U.S.) (glecaprevir/pibrentasvir). Please visit
www.enanta.com for more information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190610005329/en/
Investor ContactCarol
Miceli617-607-0710cmiceli@enanta.com
Enanta Pharmaceuticals (NASDAQ:ENTA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Enanta Pharmaceuticals (NASDAQ:ENTA)
Historical Stock Chart
From Sep 2023 to Sep 2024